Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful weapon in the fight against high-grade gliomas, a highly invasive cancer that sends cancerous cells throughout the brain and spinal cord. Chlorotoxin binds specifically to tumor cells–but not normal cells.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Improvements in surgical techniques and combination therapies increased the 1-year survival rate for lung cancer from 34 percent in 1975-1977 to 45 percent in 2006-2009.  
  • There are nearly 14.5 million people in the U.S. living with a history of cancer.  
  • Following the current path, breast cancer incidence rate will increase by 50.8% between 2003 and 2023. If an alternative path is taken, cases will increase by 32.2% between 2003 and…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…  
  • Medicines in Devlopment for Cancer, 2008